US-based Metsera is among the many companies focusing on developing drugs for the global obesity market.
发布者：BY MARIA OUTZE NIELSEN，转转请注明出处：https://robotalks.cn/weight-loss-drug-developer-targets-usd-1-78bn-valuation-on-nasdaq/
Weight-loss drug developer targets USD 1.78bn valuation on Nasdaq
赞 (0)
关于作者
相关推荐
-
Fugro pioneers uncrewed subsea inspections in Brazil for Petrobras
Petrobras, a Brazilian international oil sector titan, has actually authorized a 175-day addendum to Fugro’s existing evaluation, repair service and upkeep solutions agreemen…
-
Simplifying the Complex: The Role of UI/UX in Industrial Automation
Integrating advanced applied sciences with robots, self sustaining machines, Synthetic Intelligence, and varied applied sciences to accept diverse procedures in industrial automation processes yields efficiencies and mark financial savings. Alternatively, oversight by human operators is required. These are on the total now not programmers or computer scientists but personnel acquainted with the tools and supposed
-
TRACO Power Announces TSR 2N & TSR 3N POL Converters
TRACO Power is happy to introduce the launch of the brand-new TSR 2N & TSR 3N cost-effective POL converters.
-
Semiconductor radiation detectors designed for extreme environments
A collaborative team led by researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has successfully developed advanced semiconductor-based rad…
-
Booz Allen Ventures Invests in Starfish Space to Enhance Satellite Servicing Technology
MCLEAN, Va.–( COMPANY CABLE)– Booz Allen Hamilton (NYSE: BAH) today introduced that its company equity capital arm, Booz Allen Ventures, LLC, has actually made a critic…
